Cargando…

Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis

Detalles Bibliográficos
Autor principal: Vansteenkiste, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ESMO Open 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682357/
https://www.ncbi.nlm.nih.gov/pubmed/29147577
http://dx.doi.org/10.1136/esmoopen-2016-000119
_version_ 1783278083858497536
author Vansteenkiste, Johan
author_facet Vansteenkiste, Johan
author_sort Vansteenkiste, Johan
collection PubMed
description
format Online
Article
Text
id pubmed-5682357
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher ESMO Open
record_format MEDLINE/PubMed
spelling pubmed-56823572017-11-16 Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis Vansteenkiste, Johan ESMO Open Editorial ESMO Open 2017-03-07 /pmc/articles/PMC5682357/ /pubmed/29147577 http://dx.doi.org/10.1136/esmoopen-2016-000119 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Editorial
Vansteenkiste, Johan
Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
title Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
title_full Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
title_fullStr Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
title_full_unstemmed Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
title_short Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
title_sort nivolumab for nsclc in japanese patients: similar benefits, but beware of pneumonitis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682357/
https://www.ncbi.nlm.nih.gov/pubmed/29147577
http://dx.doi.org/10.1136/esmoopen-2016-000119
work_keys_str_mv AT vansteenkistejohan nivolumabfornsclcinjapanesepatientssimilarbenefitsbutbewareofpneumonitis